# Complion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/complion

- Industry: Software
- Headquarters: Cleveland, US
- Website: www.complion.com
- Total disclosed funding: $7M
- Latest round: Series B (Feb 12, 2019)
- Investors on record: 4

## About

Complion Inc. is a technology company that provides a comprehensive eClinical platform catering to the needs of the clinical research industry, streamlining clinical trial management through innovative software solutions.Complion Inc. was founded in 2013 and is headquartered in Cleveland, US. It specializes in providing eClinical solutions for clinical research. The company has completed 6 deals to date, with its most recent funding round being a Series B of USD 7.00 mn led by Beringea Private Equity on December 7, 2022, bringing the total amount raised to USD 7.00 mn.Complion Inc. offers a comprehensive eClinical platform that includes the Site Operations Management System (SOMS), Clinical Trial Management System (CTMS), electronic regulatory submissions (eReg / eISF), electronic source data capture (eSource), payment solutions (Pay), texting services (Text), electronic consent (eConsent), and patient engagement tools (Engage!). Their solutions enhance clinical trial efficiency by automating data capture and improving performance tracking, serving clients primarily in North America and Europe.Complion Inc. generates revenue through subscription-based models for its software products, primarily engaging clients such as research sites and contract research organizations (CROs) through multi-year agreements. This business model provides ongoing access to software updates and customer support, with flagship products like SOMS and CTMS playing a significant role in the revenue strategy.Following its acquisition by RealTime Software Solutions, LLC in December 2022, Complion plans to expand its product offerings and geographic reach. The company is exploring the development of new tools and enhancements for its eClinical platform, aiming to enter new markets by 2024. Recent funding will support these initiatives, ensuring the company can innovate and adapt to the evolving landscape of clinical research.

## Funding rounds

- Series B, Feb 12, 2019, $7M — Beringea, Ohio Innovation Fund, JumpStart, Rev1 Ventures

## Investors

- Beringea (https://capitalatlas.ai/funds/beringea) — Series B
- Ohio Innovation Fund (https://capitalatlas.ai/funds/ohio-innovation-fund) — Series B
- JumpStart (https://capitalatlas.ai/funds/jumpstart) — Series B
- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Series B